164 related articles for article (PubMed ID: 17367869)
1. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk.
Gremlich S; Nguyen D; Reymondin D; Hohlfeld P; Vial Y; Witkin SS; Gerber S
J Reprod Immunol; 2007 Jun; 74(1-2):143-51. PubMed ID: 17367869
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
3. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
[TBL] [Abstract][Full Text] [Related]
4. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
[TBL] [Abstract][Full Text] [Related]
6. Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction.
Murisier-Petetin G; Gremlich S; Damnon F; Reymondin D; Hohlfeld P; Gerber S
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):15-20. PubMed ID: 19217707
[TBL] [Abstract][Full Text] [Related]
7. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
8. MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
Wu LM; Zhang F; Xie HY; Xu X; Chen QX; Yin SY; Liu XC; Zhou L; Xu XB; Sun YL; Zheng SS
Clin Genet; 2008 Mar; 73(3):273-8. PubMed ID: 18177474
[TBL] [Abstract][Full Text] [Related]
9. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181
[TBL] [Abstract][Full Text] [Related]
12. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
[TBL] [Abstract][Full Text] [Related]
14. Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction.
Sziller I; Babula O; Hupuczi P; Nagy B; Rigó B; Szabó G; Papp Z; Linhares IM; Witkin SS
Mol Hum Reprod; 2007 Apr; 13(4):281-5. PubMed ID: 17314117
[TBL] [Abstract][Full Text] [Related]
15. Association of MMP2 and MMP9 gene polymorphisms with the recurrent spontaneous abortion: A meta-analysis.
Yan Y; Fang L; Li Y; Yu Y; Li Y; Cheng JC; Sun YP
Gene; 2021 Jan; 767():145173. PubMed ID: 33007375
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
18. Functional SNP -1562C/T in the promoter region of MMP9 and recurrent early pregnancy loss.
Singh K; Nair RR; Khanna A
Reprod Biomed Online; 2012 Jan; 24(1):61-5. PubMed ID: 22118839
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Awakura Y; Ito N; Nakamura E; Takahashi T; Kotani H; Mikami Y; Manabe T; Kamoto T; Habuchi T; Ogawa O
Cancer Lett; 2006 Sep; 241(1):59-63. PubMed ID: 16466849
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia.
Coolman M; de Maat M; Van Heerde WL; Felida L; Schoormans S; Steegers EA; Bertina RM; de Groot CJ
Placenta; 2007 Jul; 28(7):709-13. PubMed ID: 17137622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
